Oxidative Stress in Structural Valve Deterioration: A Longitudinal Clinical Study.

Area of Science:

• Biomaterials Science
• Cardiovascular Research
• Oxidative Stress Studies

Background:

• Structural valve deterioration (SVD) is a primary limitation of bioprosthetic heart valves (BHVs).
• The precise mechanisms driving SVD remain incompletely understood.
• Oxidative stress is implicated in various biological processes and tissue damage.

Purpose of the Study:

• To investigate the association between specific oxidative stress markers and SVD in patients with BHVs.
• To evaluate the temporal changes in oxidative stress markers following BHV implantation.
• To determine if oxidative stress levels differ between patients with and without SVD.

Main Methods:

• Serum samples were collected from patients with SVD and BHV patients at various time points post-implantation (0-24 months and >48 months).
• Assays were performed to measure total antioxidant capacity (TAC), malondialdehyde (MDA), and nitrotyrosine (NT) levels.
• Statistical analysis was used to compare marker levels between groups and over time.

Main Results:

• Malondialdehyde (MDA) levels increased early post-surgery, with higher levels at 6 months in incipient SVD patients.
• Nitrotyrosine (NT) levels showed a gradual increase within the first 24 months post-implantation.
• Transcatheter aortic valve implantation (TAVI) patients exhibited elevated stress markers; MDA and NT levels decreased in established SVD groups after 48 months.

Conclusions:

• Oxidative stress plays a significant role in BHV dysfunction, particularly early after implantation and in TAVI cases.
• While oxidative stress markers increase post-implantation, their levels decrease as SVD progresses.
• Oxidative stress markers may serve as potential therapeutic targets and biomarkers for BHV dysfunction.